Please login to the form below

Not currently logged in

CDK4/6 inhibitors

This page shows the latest CDK4/6 inhibitors news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s two advanced breast cancer trials meet primary endpoints

AstraZeneca’s two advanced breast cancer trials meet primary endpoints

Endocrine therapies that target ER-driven disease are widely used as first-line treatment for these forms of breast cancer in the advanced setting, and often paired with CDK4/6 inhibitors. ... However, resistance to CDK4/6 inhibitors and current

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...